P. Haroldsen
发表
S. Gaskell,
M. H. Reilly,
P. Haroldsen,
1988,
Biomedical & environmental mass spectrometry.
C. O’Neill,
D. Musson,
P. Haroldsen,
2015,
Clinical therapeutics.
S. Gaskell,
W. Mathews,
P. Haroldsen,
1989,
Rapid communications in mass spectrometry : RCM.
D. Musson,
P. Haroldsen,
Z. Sisic,
2017,
Clinical therapeutics.
S. Gaskell,
S. Weintraub,
R. N. Pinckard,
1991,
Journal of lipid research.
S. Gaskell,
P. Haroldsen,
1989,
Biomedical & environmental mass spectrometry.
S. Gaskell,
M. H. Reilly,
P. Haroldsen,
1988,
Biomedical & environmental mass spectrometry.
N. Voelkel,
R. Murphy,
P. Henson,
1987,
The Journal of clinical investigation.
R. Murphy,
P. Haroldsen,
1987,
Biomedical & environmental mass spectrometry.
R. Murphy,
K. Clay,
P. Haroldsen,
1987,
Journal of lipid research.
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
B. Byrne,
R. Barohn,
P. Laforêt,
2017,
Orphanet Journal of Rare Diseases.
P. Haroldsen,
1994,
Rapid communications in mass spectrometry : RCM.
Steven W. Johnson,
G. Rogers,
Sheng Zhong,
2011,
Bioorganic & medicinal chemistry letters.
Steven A. Johnson,
Sheng Zhong,
R. Mueller,
2011,
Bioorganic & medicinal chemistry letters.
T. A. French,
J. Gal,
T. Zysset,
1982,
Drug metabolism and disposition: the biological fate of chemicals.
C. O’Neill,
L. Tsuruda,
D. Musson,
2014,
Pharmacology research & perspectives.
C. O’Neill,
L. Tsuruda,
M. Butt,
2017,
The Journal of Pharmacology and Experimental Therapeutics.
B. Hoffer,
R. Freedman,
S. Johnson,
1984,
The Journal of pharmacology and experimental therapeutics.